⌘K
Loading ticker…
As of 2026-08-24, Sabra Healthcare REIT, Inc. (SBRA) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 2.5%, relative volume 0.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SBRA is in a stage 2 uptrend, week 2. Currently in a 20-day base; basing ADR 2.4% (broad 2.5%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 1.3% / 3.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SBRA appears in 1 ETF as of Jun 2026: BYRE at 4.43% weight, $1M notional.
Held by 119 ETFs · $1.3B across latest filings · largest weight 4.43% (BYRE).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| BYRE | 4.43% | $1M | −1.08 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SBRA Jan avg: -0.64% median: -2.31% win: 25% σ: 6.55% n: 4 2022-04-12 → 2026-07-31 | SBRA Feb avg: 0.35% median: 1.73% win: 50% σ: 9.12% n: 4 2022-04-12 → 2026-07-31 | SBRA Mar avg: 0.43% median: 0.87% win: 50% σ: 6.33% n: 4 2022-04-12 → 2026-07-31 | SBRA Apr avg: -2.23% median: -0.87% win: 40% σ: 8.19% n: 5 2022-04-12 → 2026-07-31 | SBRA May avg: 3.58% median: -1.23% win: 40% σ: 9.83% n: 5 2022-04-12 → 2026-07-31 | SBRA Jun avg: 2.65% median: 4.53% win: 60% σ: 3.58% n: 5 2022-04-12 → 2026-07-31 | SBRA Jul avg: 6.44% median: 8.51% win: 80% σ: 5.24% n: 5 2022-04-12 → 2026-07-31 | SBRA Aug avg: 1.18% median: 1.13% win: 50% σ: 5.01% n: 4 2022-04-12 → 2026-07-31 (current) | SBRA Sep avg: 1.41% median: 3.38% win: 50% σ: 10.99% n: 4 2022-04-12 → 2026-07-31 | SBRA Oct avg: 0.45% median: 0.98% win: 50% σ: 4.40% n: 4 2022-04-12 → 2026-07-31 | SBRA Nov avg: 1.89% median: 1.79% win: 50% σ: 7.46% n: 4 2022-04-12 → 2026-07-31 | SBRA Dec avg: -4.11% median: -3.32% win: 0% σ: 2.36% n: 4 2022-04-12 → 2026-07-31 |